Following a long-awaited submission of data to the Food and Drug Administration last month, Novavax announced Monday that it had formally filed a request for emergency use authorization of its protein ...
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus, has become a global health emergency. Since it was first ...
In a recent study posted to the bioRxiv* preprint server, researchers demonstrated that a trivalent vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) improved the breadth of ...
WASHINGTON — The Centers for Disease Control and Prevention on Tuesday recommended the use of Novavax’s COVID-19 vaccine in adults aged 18 and older just hours after an influential advisory panel gave ...
A new protein subunit vaccine may offer an inexpensive, easy-to-store, and effective alternative to RNA vaccines for COVID-19. While many people in wealthier countries have been vaccinated against ...
The Centers for Disease Control and Prevention signed off on Novavax's COVID-19 vaccine on Tuesday. In a statement, the CDC said the shots will be available in the coming weeks. The U.S. has secured 3 ...
A vaccine authorized in December for use in India may help solve one of the most vexing problems in global public health: How to supply lower income countries a COVID-19 vaccine that is safe, ...
Novavax Could Offer Unvaccinated Americans A New Option, If Regulators Agree Following a long-awaited submission of data to the Food and Drug Administration last month, Novavax announced Monday that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback